May 2020
SAFETY OBSERVER N167
17 PAGES
COVID-19 Guidance
PV Inspection Metrics
New SAHPRA PV guidance
And more...
PUBLICATIONS / NUMBER 167
Stay on top of all key Pharmacovigilance Regulatory requirements
We do the search and bring you the regulatory information you need to achieve compliancein your Pharmacovigilance operations.
Latest ReleaseSafety Observer 170EU Clinical Trials Regulation
New FDA Draft Guidance
MHRA Post-Brexit Guidance
GPvP in Brazil
CIOMS Guides
Safety Observer 169COVID-19 Guidance
New CIOMS DILI Guidance
FDA updates E2B Guidance
FDA updates REMS Guidance
EU PV Training Material
Choose the number of users for this product
Number of users
- 1 user
- 2 to 5 users
- 6 to 14 users
- 15 to 49 users
- 50 and + users
